The Baclofen Tablets, cataloged under National Stock Number 6505-01-094-7542, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Danbury Pharmacal Inc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-094-7542 |
| Primary Part Number | NDC00591-5730-01 |
| Item Name | Baclofen Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Danbury Pharmacal Inc |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 10.000 TABLETS |
| Supplementary Features | MEDSEP ITEM FOR DOD,CIBA-GEIGY |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | STRIP |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00591-5730-01 | Danbury Pharmacal Inc (USA) |
| NDC00904-3365-61 | Major Pharmaceuticals Inc (USA) |
| NDC00173-4096-60 | Zenith Laboratories Inc (USA) |
| NDC00832-1024-00 | Pharmaceutical Basics Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00028-0023-61 | 3/2 Design control — primary reference U.S. Government activity |
| LIORESAL | 5/1 Secondary reference U.S. Government activity |
| LIORESAL TABLETS | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-094-7542 is a Baclofen Tablets, manufactured by Danbury Pharmacal Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-094-7542 has 4 manufacturer part numbers on file: NDC00591-5730-01 (Danbury Pharmacal Inc), NDC00904-3365-61 (Major Pharmaceuticals Inc), NDC00173-4096-60 (Zenith Laboratories Inc), NDC00832-1024-00 (Pharmaceutical Basics Inc).
Key specifications for NDC00591-5730-01: Administration: ORAL; Primary Container Content Quantity: 10.000 TABLETS; Supplementary Features: MEDSEP ITEM FOR DOD,CIBA-GEIGY; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.